1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Europe Human Insulin Industry 2015 Market Research Report

Europe Human Insulin Industry 2015 Market Research Report

  • September 2015
  • -
  • QY Research Group
  • -
  • 131 pages

Summary


The Europe Human Insulin Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Human Insulin industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Human Insulin market analysis is provided for the Europe markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on Europe major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Human Insulin industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 143 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table Of Contents

Europe Human Insulin Industry 2015 Market Research Report
Table of Contents

Chapter One Industry Overview
1.1 Definition and Specifications of Human Insulin
1.2 Classification of Human Insulin
1.3 Applications of Human Insulin
1.4 Industry Chain Structure of Human Insulin
1.5 Industry Overview of Human Insulin
1.6 Industry Policy Analysis of Human Insulin
1.7 Industry News Analysis of Human Insulin

Chapter Two Manufacturing Cost Structure Analysis of Human Insulin
2.1 Bill of Materials (BOM) of Human Insulin
2.2 BOM Price Analysis of Human Insulin
2.3 Labor Cost Analysis of Human Insulin
2.4 Depreciation Cost Analysis of Human Insulin
2.5 Manufacturing Cost Structure Analysis of Human Insulin
2.6 Manufacturing Process Analysis of Human Insulin

Chapter Three Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of Europe Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of Europe Key Human Insulin Manufacturers in 2014
3.3 RandD Status and Technology Source of Europe Human Insulin Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of Europe Human Insulin Key Manufacturers in 2014

Chapter Four Production Analysis of Human Insulin by Regions, Technology, and Applications
4.1 Europe Production of Human Insulin by Regions (Key Provinces) 2010-2015
4.2 Europe Production of Human Insulin by Product Types 2010-2015
4.3 Europe Sales of Human Insulin by Applications 2010-2015
4.4 Price Analysis of Europe Human Insulin Key Manufacturers in 2015
4.5 Europe Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Human Insulin 2010-2015

Chapter Five Sales and Revenue Analysis of Human Insulin by Regions
5.1 Europe Sales of Human Insulin by Regions 2010-2015
5.2 Europe Revenue of Human Insulin by Regions 2010-2015
5.3 Europe Price Analysis of Human Insulin Sales by Regions 2010-2015
5.4 Europe Price, Cost and Gross of Human Insulin 2010-2015

Chapter Six Analysis of Human Insulin Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity Production Sales Revenue of Human Insulin 2010-2015
6.2 Production Sales Market Share Analysis of Human Insulin 2014-2015
6.3 Import, Export and Consumption of Human Insulin 2010-2015
6.4 Supply, Consumption and Shortage of Human Insulin 2010-2015
6.5 Import, Export and Consumption of Human Insulin 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Human Insulin 2010-2015

Chapter Seven Analysis of Human Insulin Industry Key Manufacturers
7.1 Novo Nordisk
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 Novo Nordisk SWOT Analysis

7.2 Eli Lilly
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 Eli Lilly SWOT Analysis

7.3 Sanofi
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Sanofi SWOT Analysis

7.4 Oramed Pharmaceuticals
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 Oramed Pharmaceuticals SWOT Analysis

7.5 Merck
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.5.4 Merck SWOT Analysis

7.6 Diamyd Medical
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.6.4 Diamyd Medical SWOT Analysis

7.7 Biodel
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.7.4 Biodel SWOT Analysis

7.8 Biocon
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.8.4 Biocon SWOT Analysis

7.9 Biogenomics
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.9.4 Biogenomics SWOT Analysis

7.10 Boehringer Ingelheim 
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.10.4 Boehringer Ingelheim  SWOT Analysis

7.11 Bristol-Myers Squibb
7.11.1 Company Profile
7.11.2 Product Picture and Specification
7.11.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.11.4 Bristol-Myers Squibb SWOT Analysis

7.12 Lexicon Pharmaceuticals
7.12.1 Company Profile
7.12.2 Product Picture and Specification
7.12.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.12.4 Lexicon Pharmaceuticals SWOT Analysis

7.13 Diasome Pharmaceuticals
7.13.1 Company Profile
7.13.2 Product Picture and Specification
7.13.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.13.4 Diasome Pharmaceuticals SWOT Analysis

7.14 DiaVacs 
7.14.1 Company Profile
7.14.2 Product Picture and Specification
7.14.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.14.4 DiaVacs  SWOT Analysis

7.15 Pfizer 
7.15.1 Company Profile
7.15.2 Product Picture and Specification
7.15.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.15.4 Pfizer  SWOT Analysis

7.16 Generex Biotechnology 
7.16.1 Company Profile
7.16.2 Product Picture and Specification
7.16.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.16.4 Generex Biotechnology  SWOT Analysis

7.17 Macrogenics
7.17.1 Company Profile
7.17.2 Product Picture and Specification
7.17.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.17.4 Macrogenics SWOT Analysis

7.18 Osiris Therapeutics
7.18.1 Company Profile
7.18.2 Product Picture and Specification
7.18.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.18.4 Osiris Therapeutics SWOT Analysis

7.19 Thermalin Diabetes
7.19.1 Company Profile
7.19.2 Product Picture and Specification
7.19.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.19.4 Thermalin Diabetes SWOT Analysis

7.20 Tolerion 
7.20.1 Company Profile
7.20.2 Product Picture and Specification
7.20.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.20.4 Tolerion  SWOT Analysis

7.21 Wockhardt
7.21.1 Company Profile
7.21.2 Product Picture and Specification
7.21.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.21.4 Wockhardt SWOT Analysis

7.22 XOMA Corporation
7.22.1 Company Profile
7.22.2 Product Picture and Specification
7.22.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.22.4 XOMA Corporation SWOT Analysis

Chapter Eight Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Human Insulin Product Types
8.5 Market Share Analysis of Different Human Insulin Price Levels
8.6 Gross Margin Analysis of Different Human Insulin Applications

Chapter Nine Marketing Trader or Distributor Analysis of Human Insulin
9.1 Marketing Channels Status of Human Insulin
9.2 Traders or Distributors of Human Insulin with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Human Insulin
9.4 Europe Import, Export and Trade Analysis of Human Insulin

Chapter Ten Development Trend of Human Insulin Industry 2015-2020
10.1 Capacity and Production Overview of Human Insulin 2015-2020
10.2 Production Market Share by Product Types of Human Insulin 2015-2020
10.3 Sales and Sales Revenue Overview of Human Insulin 2015-2020
10.4 Europe Sales of Human Insulin by Applications 2015-2020
10.5 Import, Export and Consumption of Human Insulin 2015-2020
10.6 Cost, Price, Revenue and Gross Margin of Human Insulin 2015-2020

Chapter Eleven Industry Chain Suppliers of Human Insulin with Contact Information
11.1 Major Raw Materials Suppliers of Human Insulin with Contact Information
11.2 Manufacturing Equipment Suppliers of Human Insulin with Contact Information
11.3 Major Players of Human Insulin with Contact Information
11.4 Key Consumers of Human Insulin with Contact Information
11.5 Supply Chain Relationship Analysis of Human Insulin

Chapter Twelve New Project Investment Feasibility Analysis of Human Insulin
12.1 New Project SWOT Analysis of Human Insulin
12.2 New Project Investment Feasibility Analysis of Human Insulin

Chapter Thirteen Conclusion of the Europe Human Insulin Industry 2015 Market Research Report




List of Tables and Figures

Figure Picture of Human Insulin
Table Product Specifications of Human Insulin
Table Classification of Human Insulin
Figure Europe Sales Market Share of Human Insulin by Product Types in 2014
Table Applications of Human Insulin
Figure Europe Sales Market Share of Human Insulin by Applications in 2014
Figure Industry Chain Structure of Human Insulin
Table Europe Industry Overview of Human Insulin
Table Industry Policy of Human Insulin
Table Industry News List of Human Insulin
Table Bill of Materials (BOM) of Human Insulin
Table Bill of Materials (BOM) Price of Human Insulin
Table Labor Cost of Human Insulin
Table Depreciation Cost of Human Insulin
Table Manufacturing Cost Structure Analysis of Human Insulin in 2014
Figure Manufacturing Process Analysis of Human Insulin
Table Capacity (K Units) and Commercial Production Date of Europe Human Insulin Key Manufacturers in 2014
Table Manufacturing Plants Distribution of Europe Key Human Insulin Manufacturers in 2014
Table RandD Status and Technology Source of Europe Human Insulin Key Manufacturers in 2014
Table Raw Materials Sources Analysis of Europe and Europe Human Insulin Key Manufacturers in 2014
Table Europe Production of Human Insulin by Regions 2010-2015 (K Units)
Table Europe Production Market Share of Human Insulin by Regions 2010-2015 (%)
Figure Europe Production Market Share of Human Insulin by Regions in 2014
Figure Europe Production Market Share of Human Insulin by Regions in 2015
Table Europe Production of Human Insulin by Product Types in 2010-2015 (K Units)
Table Europe Production Market Share of Human Insulin by Product Types in 2010-2015 (%)
Figure Europe Production Market Share of Human Insulin by Technology in 2014
Figure Europe Production Market Share of Human Insulin by Technology in 2015
Figure Europe Sales of Human Insulin by Applications 2010-2015 (K Units)
Table Europe Production Market Share of Human Insulin by Applications 2010-2015 (%)
Figure Europe Production Market Share of Human Insulin by Applications in 2014
Figure Europe Production Market Share of Human Insulin by Applications in 2015
Table Price Comparison of Europe Human Insulin Key Manufacturers in 2015 (USD/Unite)
Table Europe Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Human Insulin 2010-2015
Table Europe Sales of Human Insulin by Regions 2010-2015 (K Units)
Table Europe Sales Market Share of Human Insulin by Regions 2010-2015 (%)
Figure Europe Sales of Human Insulin by Regions in 2014 (K Units)
Figure Europe Sales of Human Insulin by Regions in 2015 (K Units)
Table Europe Revenue of Human Insulin by Regions 2010-2015 (M USD)
Table Europe Revenue of Human Insulin by Regions 2010-2015 (%)
Figure Europe Revenue of Human Insulin by Regions in 2014 (%)
Figure Europe Revenue of Human Insulin by Regions in 2015 (%)
Table Sales Price of Human Insulin by Regions 2010-2015 (USD/Unite)
Table Europe Price Analysis of Human Insulin 2010-2015 (USD/Unite)
Table Europe Cost Analysis of Human Insulin 2010-2015 (USD/Unite)
Table Europe Gross Analysis of Human Insulin 2010-2015
Table Europe and Major Manufacturers Capacity of Human Insulin 2010-2015 (K Units)
Table Europe Capacity Market Share of Major Human Insulin Manufacturers 2010-2015 (%)
Table Europe and Major Manufacturers Production of Human Insulin 2010-2015 (K Units)
Table Europe Production Market Share of Major Human Insulin Manufacturers 2010-2015 (%)
Table Europe and Major Manufacturers Sales of Human Insulin 2010-2015 (K Units)
Table Europe Sales Market Share of Major Human Insulin Manufacturers 2010-2015 (%)
Table Europe and Major Manufacturers Sales Revenue of Human Insulin 2010-2015 (M USD)
Table Europe Sales Revenue Market Share of Major Human Insulin Manufacturers 2010-2015 (%)
Figure Europe Capacity (K Units), Production (K Units) and Growth Rate of Human Insulin 2010-2015
Figure Europe Capacity Utilization Rate of Human Insulin 2010-2015
Figure Europe Sales Revenue (M USD) and Growth Rate of Human Insulin 2010-2015
Figure Europe Production Market Share of Major Human Insulin Manufacturers in 2014
Figure Europe Production Market Share of Major Human Insulin Manufacturers in 2015
Figure Europe Sales Market Share of Major Human Insulin Manufacturers in 2014
Figure Europe Sales Market Share of Major Human Insulin Manufacturers in 2015
Table Europe Import, Export and Consumption of Human Insulin 2010-2015 (K Units)
Table Europe and Major Manufacturers Local Sales Export Import of Human Insulin 2010-2015 (K Units)
Table Europe Supply, Consumption and Shortage of Human Insulin 2010-2015 (K Units)
Table Europe Import, Export and Consumption of Human Insulin 2010-2015 (K Units)
Table Price of Europe Human Insulin Major Manufacturers 2010-2015 (USD/Unite)
Table Gross Margin of Europe Human Insulin Major Manufacturers 2010-2015
Table Europe and Major Manufacturers Revenue of Human Insulin 2010-2015 (M USD)
Table Europe Production (K Units), Price (USD/Unite), Cost (USD/Unite), Revenue (M USD) and Gross Margin of Human Insulin 2010-2015
Table Novo Nordisk Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Human Insulin Picture and Specifications of Novo Nordisk
Table Human Insulin Capacity (K Units), Production (K Units), Price (USD/Unite), Cost (USD/Unite), Gross (USD/Unite), Revenue (M USD) and Gross Margin of Novo Nordisk 2010-2015
Figure Human Insulin Capacity (K Units), Production (K Units) and Growth Rate of Novo Nordisk 2010-2015
Figure Human Insulin Production (K Units) and Europe Market Share of Novo Nordisk 2010-2015
Table Novo Nordisk Human Insulin SWOT Analysis
Table Eli Lilly Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Human Insulin Picture and Specifications of Eli Lilly
Table Human Insulin Capacity (K Units), Production (K Units), Price (USD/Unite), Cost (USD/Unite), Gross (USD/Unite), Revenue (M USD) and Gross Margin of Eli Lilly 2010-2015
Figure Human Insulin Capacity (K Units), Production (K Units) and Growth Rate of Eli Lilly 2010-2015
Figure Human Insulin Production (K Units) and Europe Market Share of Eli Lilly 2010-2015
Table Eli Lilly Human Insulin SWOT Analysis
Table Sanofi Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Human Insulin Picture and Specifications of Sanofi
Table Human Insulin Capacity (K Units), Production (K Units), Price (USD/Unite), Cost (USD/Unite), Gross (USD/Unite), Revenue (M USD) and Gross Margin of Sanofi 2010-2015
Figure Human Insulin Capacity (K Units), Production (K Units) and Growth Rate of Sanofi 2010-2015
Figure Human Insulin Production (K Units) and Europe Market Share of Sanofi 2010-2015
Table Sanofi Human Insulin SWOT Analysis
Table Oramed Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Human Insulin Picture and Specifications of Oramed Pharmaceuticals
Table Human Insulin Capacity (K Units), Production (K Units), Price (USD/Unite), Cost (USD/Unite), Gross (USD/Unite), Revenue (M USD) and Gross Margin of Oramed Pharmaceuticals 2010-2015
Figure Human Insulin Capacity (K Units), Production (K Units) and Growth Rate of Oramed Pharmaceuticals 2010-2015
Figure Human Insulin Production (K Units) and Europe Market Share of Oramed Pharmaceuticals 2010-2015
Table Oramed Pharmaceuticals Human Insulin SWOT Analysis
Table Merck Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Human Insulin Picture and Specifications of Merck
Table Human Insulin Capacity (K Units), Production (K Units), Price (USD/Unite), Cost (USD/Unite), Gross (USD/Unite), Revenue (M USD) and Gross Margin of Merck 2010-2015
Figure Human Insulin Capacity (K Units), Production (K Units) and Growth Rate of Merck 2010-2015
Figure Human Insulin Production (K Units) and Europe Market Share of Merck 2010-2015
Table Merck Human Insulin SWOT Analysis
Table Diamyd Medical Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Human Insulin Picture and Specifications of Diamyd Medical
Table Human Insulin Capacity (K Units), Production (K Units), Price (USD/Unite), Cost (USD/Unite), Gross (USD/Unite), Revenue (M USD) and Gross Margin of Diamyd Medical 2010-2015
Figure Human Insulin Capacity (K Units), Production (K Units) and Growth Rate of Diamyd Medical 2010-2015
Figure Human Insulin Production (K Units) and Europe Market Share of Diamyd Medical 2010-2015
Table Diamyd Medical Human Insulin SWOT Analysis
Table Biodel Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Human Insulin Picture and Specifications of Biodel
Table Human Insulin Capacity (K Units), Production (K Units), Price (USD/Unite), Cost (USD/Unite), Gross (USD/Unite), Revenue (M USD) and Gross Margin of Biodel 2010-2015
Figure Human Insulin Capacity (K Units), Production (K Units) and Growth Rate of Biodel 2010-2015
Figure Human Insulin Production (K Units) and Europe Market Share of Biodel 2010-2015
Table Biodel Human Insulin SWOT Analysis
Table Biocon Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Human Insulin Picture and Specifications of Biocon
Table Human Insulin Capacity (K Units), Production (K Units), Price (USD/Unite), Cost (USD/Unite), Gross (USD/Unite), Revenue (M USD) and Gross Margin of Biocon 2010-2015
Figure Human Insulin Capacity (K Units), Production (K Units) and Growth Rate of Biocon 2010-2015
Figure Human Insulin Production (K Units) and Europe Market Share of Biocon 2010-2015
Table Biocon Human Insulin SWOT Analysis
Table Biogenomics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Human Insulin Picture and Specifications of Biogenomics
Table Human Insulin Capacity (K Units), Production (K Units), Price (USD/Unite), Cost (USD/Unite), Gross (USD/Unite), Revenue (M USD) and Gross Margin of Biogenomics 2010-2015
Figure Human Insulin Capacity (K Units), Production (K Units) and Growth Rate of Biogenomics 2010-2015
Figure Human Insulin Production (K Units) and Europe Market Share of Biogenomics 2010-2015
Table Biogenomics Human Insulin SWOT Analysis
Table Boehringer Ingelheim  Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Human Insulin Picture and Specifications of Boehringer Ingelheim 
Table Human Insulin Capacity (K Units), Production (K Units), Price (USD/Unite), Cost (USD/Unite), Gross (USD/Unite), Revenue (M USD) and Gross Margin of Boehringer Ingelheim  2010-2015
Figure Human Insulin Capacity (K Units), Production (K Units) and Growth Rate of Boehringer Ingelheim  2010-2015
Figure Human Insulin Production (K Units) and Europe Market Share of Boehringer Ingelheim  2010-2015
Table Boehringer Ingelheim  Human Insulin SWOT Analysis
Table Bristol-Myers Squibb Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Human Insulin Picture and Specifications of Bristol-Myers Squibb
Table Human Insulin Capacity (K Units), Production (K Units), Price (USD/Unite), Cost (USD/Unite), Gross (USD/Unite), Revenue (M USD) and Gross Margin of Bristol-Myers Squibb 2010-2015
Figure Human Insulin Capacity (K Units), Production (K Units) and Growth Rate of Bristol-Myers Squibb 2010-2015
Figure Human Insulin Production (K Units) and Europe Market Share of Bristol-Myers Squibb 2010-2015
Table Bristol-Myers Squibb Human Insulin SWOT Analysis
Table Lexicon Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Human Insulin Picture and Specifications of Lexicon Pharmaceuticals
Table Human Insulin Capacity (K Units), Production (K Units), Price (USD/Unite), Cost (USD/Unite), Gross (USD/Unite), Revenue (M USD) and Gross Margin of Lexicon Pharmaceuticals 2010-2015
Figure Human Insulin Capacity (K Units), Production (K Units) and Growth Rate of Lexicon Pharmaceuticals 2010-2015
Figure Human Insulin Production (K Units) and Europe Market Share of Lexicon Pharmaceuticals 2010-2015
Table Lexicon Pharmaceuticals Human Insulin SWOT Analysis
Table Diasome Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Human Insulin Picture and Specifications of Diasome Pharmaceuticals
Table Human Insulin Capacity (K Units), Production (K Units), Price (USD/Unite), Cost (USD/Unite), Gross (USD/Unite), Revenue (M USD) and Gross Margin of Diasome Pharmaceuticals 2010-2015
Figure Human Insulin Capacity (K Units), Production (K Units) and Growth Rate of Diasome Pharmaceuticals 2010-2015
Figure Human Insulin Production (K Units) and Europe Market Share of Diasome Pharmaceuticals 2010-2015
Table Diasome Pharmaceuticals Human Insulin SWOT Analysis
Table DiaVacs  Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Human Insulin Picture and Specifications of DiaVacs 
Table Human Insulin Capacity (K Units), Production (K Units), Price (USD/Unite), Cost (USD/Unite), Gross (USD/Unite), Revenue (M USD) and Gross Margin of DiaVacs  2010-2015
Figure Human Insulin Capacity (K Units), Production (K Units) and Growth Rate of DiaVacs  2010-2015
Figure Human Insulin Production (K Units) and Europe Market Share of DiaVacs  2010-2015
Table DiaVacs  Human Insulin SWOT Analysis
Table Pfizer  Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Human Insulin Picture and Specifications of Pfizer 
Table Human Insulin Capacity (K Units), Production (K Units), Price (USD/Unite), Cost (USD/Unite), Gross (USD/Unite), Revenue (M USD) and Gross Margin of Pfizer  2010-2015
Figure Human Insulin Capacity (K Units), Production (K Units) and Growth Rate of Pfizer  2010-2015
Figure Human Insulin Production (K Units) and Europe Market Share of Pfizer  2010-2015
Table Pfizer  Human Insulin SWOT Analysis
Table Generex Biotechnology  Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Human Insulin Picture and Specifications of Generex Biotechnology 
Table Human Insulin Capacity (K Units), Production (K Units), Price (USD/Unite), Cost (USD/Unite), Gross (USD/Unite), Revenue (M USD) and Gross Margin of Generex Biotechnology  2010-2015
Figure Human Insulin Capacity (K Units), Production (K Units) and Growth Rate of Generex Biotechnology  2010-2015
Figure Human Insulin Production (K Units) and Europe Market Share of Generex Biotechnology  2010-2015
Table Generex Biotechnology  Human Insulin SWOT Analysis
Table Macrogenics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Human Insulin Picture and Specifications of Macrogenics
Table Human Insulin Capacity (K Units), Production (K Units), Price (USD/Unite), Cost (USD/Unite), Gross (USD/Unite), Revenue (M USD) and Gross Margin of Macrogenics 2010-2015
Figure Human Insulin Capacity (K Units), Production (K Units) and Growth Rate of Macrogenics 2010-2015
Figure Human Insulin Production (K Units) and Europe Market Share of Macrogenics 2010-2015
Table Macrogenics Human Insulin SWOT Analysis
Table Osiris Therapeutics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Human Insulin Picture and Specifications of Osiris Therapeutics
Table Human Insulin Capacity (K Units), Production (K Units), Price (USD/Unite), Cost (USD/Unite), Gross (USD/Unite), Revenue (M USD) and Gross Margin of Osiris Therapeutics 2010-2015
Figure Human Insulin Capacity (K Units), Production (K Units) and Growth Rate of Osiris Therapeutics 2010-2015
Figure Human Insulin Production (K Units) and Europe Market Share of Osiris Therapeutics 2010-2015
Table Osiris Therapeutics Human Insulin SWOT Analysis
Table Thermalin Diabetes Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Human Insulin Picture and Specifications of Thermalin Diabetes
Table Human Insulin Capacity (K Units), Production (K Units), Price (USD/Unite), Cost (USD/Unite), Gross (USD/Unite), Revenue (M USD) and Gross Margin of Thermalin Diabetes 2010-2015
Figure Human Insulin Capacity (K Units), Production (K Units) and Growth Rate of Thermalin Diabetes 2010-2015
Figure Human Insulin Production (K Units) and Europe Market Share of Thermalin Diabetes 2010-2015
Table Thermalin Diabetes Human Insulin SWOT Analysis
Table Tolerion  Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Human Insulin Picture and Specifications of Tolerion 
Table Human Insulin Capacity (K Units), Production (K Units), Price (USD/Unite), Cost (USD/Unite), Gross (USD/Unite), Revenue (M USD) and Gross Margin of Tolerion  2010-2015
Figure Human Insulin Capacity (K Units), Production (K Units) and Growth Rate of Tolerion  2010-2015
Figure Human Insulin Production (K Units) and Europe Market Share of Tolerion  2010-2015
Table Tolerion  Human Insulin SWOT Analysis
Table Wockhardt Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Human Insulin Picture and Specifications of Wockhardt
Table Human Insulin Capacity (K Units), Production (K Units), Price (USD/Unite), Cost (USD/Unite), Gross (USD/Unite), Revenue (M USD) and Gross Margin of Wockhardt 2010-2015
Figure Human Insulin Capacity (K Units), Production (K Units) and Growth Rate of Wockhardt 2010-2015
Figure Human Insulin Production (K Units) and Europe Market Share of Wockhardt 2010-2015
Table Wockhardt Human Insulin SWOT Analysis
Table XOMA Corporation Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Human Insulin Picture and Specifications of XOMA Corporation
Table Human Insulin Capacity (K Units), Production (K Units), Price (USD/Unite), Cost (USD/Unite), Gross (USD/Unite), Revenue (M USD) and Gross Margin of XOMA Corporation 2010-2015
Figure Human Insulin Capacity (K Units), Production (K Units) and Growth Rate of XOMA Corporation 2010-2015
Figure Human Insulin Production (K Units) and Europe Market Share of XOMA Corporation 2010-2015
Table XOMA Corporation Human Insulin SWOT Analysis
Table Human Insulin Price by Regions 2010-2015
Table Human Insulin Price by Product Types 2010-2015
Table Human Insulin Price by Company 2010-2015
Table Human Insulin Gross Margin by Company 2010-2015
Table Price Comparison of Human Insulin by Regions 2010-2015 (USD/Unite)
Table Price of Different Human Insulin Product Types (USD/Unite)
Table Market Share of Different Human Insulin Price Level
Table Gross Margin of Different Human Insulin Applications
Table Marketing Channels Status of Human Insulin
Table Traders or Distributors of Human Insulin with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Human Insulin (USD/Unite)
Table Europe Import, Export, and Trade of Human Insulin (K Units)
Figure Europe Capacity (K Units), Production (K Units) and Growth Rate of Human Insulin 2015-2020
Figure Europe Capacity Utilization Rate of Human Insulin 2015-2020
Table Europe Human Insulin Production by Product Types 2010-2015 (K Units)
Table Europe Human Insulin Production Market Share by Product Types 2010-2015 (%)
Figure Europe Production Market Share of Human Insulin by Technology in 2020
Figure Europe Sales (K Units) and Growth Rate of Human Insulin 2015-2020
Figure Europe Sales Revenue (Million USD) and Growth Rate of Human Insulin 2015-2020
Figure Europe Sales of Human Insulin by Applications 2015-2020 (K Units)
Table Europe Production Market Share of Human Insulin by Applications 2015-2020 (%)
Figure Europe Production Market Share of Human Insulin by Applications in 2020
Table Europe Production, Import, Export and Consumption of Human Insulin 2015-2020 (K Units)
Table Europe Production (K Units), Price (USD/Unite), Cost (USD/Unite), Revenue (M USD) and Gross Margin of Human Insulin 2015-2020
Table Major Raw Materials Suppliers of Human Insulin with Contact Information
Table Manufacturing Equipment Suppliers of Human Insulin with Contact Information
Table Major Players of Human Insulin with Contact Information
Table Key Consumers of Human Insulin with Contact Information
Table Supply Chain Relationship Analysis of Human Insulin
Table New Project SWOT Analysis of Human Insulin
Table New Project Investment Feasibility Analysis of Human Insulin
Table Part of Interviewees Record List

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Type 2 Diabetes Mellitus: KOL Insight 2016

Type 2 Diabetes Mellitus: KOL Insight 2016

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Can top-ranked GLP1 agonists move out of the third-line setting? GLP1 agonists may be the top-ranked type 2 diabetes mellitus (T2DM) treatment according to the American Association of Clinical Endocrinologists ...

European Market Report for Modern Insulin 2016 - MedCore

European Market Report for Modern Insulin 2016 - MedCore

  • $ 5995
  • Industry report
  • September 2016
  • by iData Research, Inc.

The European modern insulin market can be segmented by insulin type, yielding three segments: long-acting insulin, rapid-acting insulin and premixed insulin. In 2015, the largest segment in the total modern ...

US Market Report for Insulin 2017 - MedCore

US Market Report for Insulin 2017 - MedCore

  • $ 5495
  • Industry report
  • November 2016
  • by iData Research, Inc.

Description The U.S. insulin market can be segmented by insulin type, yielding four segments: long-acting insulin, rapid-acting insulin, premixed insulin and human insulin. In 2016, the largest segment ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.